The relationship between dietary profile and adherence to the Mediterranean diet with EDSS and quality of life in multiple sclerosis patients: a retrospective cross-sectional study

References

• Brownlee WJ, Hardy TA, Fazekas F, et al. Diagnosis of multiple sclerosis: progress and challenges. Lancet. 2017;389:1336–46.
   PubMed Web of Science ®Google Scholar
• Ghareghani M, Reiter RJ, Zibara K, et al. Latitude, vitamin D, melatonin, and gut microbiota act in concert to initiate multiple sclerosis: a new mechanistic pathway. Front Immunol [Internet]. 2018;9:2484. Available from: https://www.frontiersin.org/article/10.3389fimmu.2018.02484/full.
   PubMed Web of Science ®Google Scholar
• Ochoa-Morales A, Hernández-Mojica T, Paz-Rodríguez F, et al. Quality of life in patients with multiple sclerosis and its association with depressive symptoms and physical disability. Mult Scler Relat Disord. 2019;36:101386.
   PubMed Web of Science ®Google Scholar
• Francis HM, Stevenson RJ. Potential for diet to prevent and remediate cognitive deficits in neurological disorders. Nutr Rev. 2018;76:204–17.
   PubMed Web of Science ®Google Scholar
• Jelinek GA, de Livera AM, Marck CH, et al. Lifestyle, medication and socio-demographic determinants of mental and physical health-related quality of life in people with multiple sclerosis. BMC Neurol. 2016;16:1–9.
   PubMed Web of Science ®Google Scholar
• Bromley L, Horvath PJ, Bennett SE, et al. Impact of nutritional intake on function in people with mild-to-moderate multiple sclerosis. Int J MS Care. 2019;21:1–9.
   PubMedGoogle Scholar
• Fitzgerald K. Diet and disease modification in multiple sclerosis: a nutritional epidemiology perspective. J Neurol Neurosurg Psychiatry. 2018;89:3.
   PubMed Web of Science ®Google Scholar
• Bagur MJ, Murcia MA, Jiménez-Monreal AM, Tur JA, Bibiloni MM, Alonso GL M-TM. Influence of diet in multiple sclerosis: a systematic review. Am Soc Nutr. 2017;8:463–72.
   Google Scholar
• Esposito S, Sparaco M, Maniscalco GT, et al. Lifestyle and Mediterranean diet adherence in a cohort of southern Italian patients with multiple sclerosis. Mult Scler Relat Disord. 2021;47:102636.
   PubMed Web of Science ®Google Scholar
• Schulpen M, van den Brandt PA. Adherence to the Mediterranean diet and overall cancer incidence: the Netherlands cohort study. J Acad Nutr Diet. 2021;121:242–52.
   PubMed Web of Science ®Google Scholar
• Black LJ, Baker K, Ponsonby AL, et al. A higher mediterranean diet score, including unprocessed red meat, is associated with reduced risk of central nervous system demyelination in a case-control study of Australian adults. J Nutr. 2019;149:1385–92.
   PubMed Web of Science ®Google Scholar
• Jakimovski D, Guan Y, Ramanathan M, et al. Lifestyle-based modifiable risk factors in multiple sclerosis: review of experimental and clinical findings. Neurodegener Dis Manag. 2019;9:149–72.
   PubMed Web of Science ®Google Scholar
• Sand I K, Benn EKT, Fabian M, et al. Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: a pilot study. Mult Scler Relat Disord. 2019;36:101403.
   PubMed Web of Science ®Google Scholar
• Sand I K, Levy S, Fitzgerald K, et al. Mediterranean diet is linked to less objective disability in multiple sclerosis. Multiple Scler J. 2022;29(2):248–260.
   PubMed Web of Science ®Google Scholar
• Sand I K, Fitzgerald K, Sorets T, et al. Mediterranean diet score is associated with disability and brain atrophy in multiple sclerosis. The 2022 AAN Annual Meeting. Seattle, Washington; 2022.
   Google Scholar
• Jelinek GA, Hadgkiss EJ, Weiland TJ, et al. Association of fish consumption and omega 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis. Int J Neurosci. 2013;123:792–801.
   PubMed Web of Science ®Google Scholar
• Marck CH, Probst Y, Chen J, et al. Dietary patterns and associations with health outcomes in Australian people with multiple sclerosis. Eur J Clin Nutr. 2021;75:1506–14.
   PubMed Web of Science ®Google Scholar
• Ford H. Clinical presentation and diagnosis of multiple sclerosis. Clin Med J R Coll Physicians Lond. 2020;20:380–3.
   PubMed Web of Science ®Google Scholar
• Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83:278–86.
   PubMed Web of Science ®Google Scholar
• Samjoo IA, Worthington E, Drudge C, et al. Efficacy classification of modern therapies in multiple sclerosis. J Comp Eff Res. 2021;10(6):495–507.
   PubMed Web of Science ®Google Scholar
• Iaffaldano P, Lucisano G, Caputo F, et al. Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies. Ther Adv Neurol Disord. 2021;14:1–10.
   Web of Science ®Google Scholar
• Wiendl H, Gold R, Berger T, et al. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Ther Adv Neurol Disord. 2021;14:1–39.
   Web of Science ®Google Scholar
• Pekcan G. Beslenme durumunun saptanması. Diyet El Kitabı. Ankara: Hatiboğlu Yayınevi; 2008.
   Google Scholar
• Rakıcıoğlu N, Tek N, Ayaz A, et al. Yemek ve Besin Fotoğraf Kataloğu. Ölçü ve Miktarlar (Turkish). 5. Baskı. Ankara: Hatiboğlu Yayınevi; 2012.
   Google Scholar
• Türkiye Beslenme Rehberi. Ankara: T.C. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu,Obezite, Diyabet ve Metabolik Hastalıklar Daire Başkanlığı; 2015.
   Google Scholar
• Özkan Pehlivanoğlu EF, Balcıoğlu H, Ünlüoğlu İ. Akdeniz Diyeti Bağlılık Ölçeği’nin Türkçe’ye Uyarlanması Geçerlilik ve Güvenilirliği. Osmangazi Tıp Dergisi. 2020;42:160–4.
   Google Scholar
• Haliloǧlu E, Içaǧasioglu A, Baklacioglu HŞ, et al. Multipl sklerozda yaşam kalitesinin fonksiyonel durum He iliskişi. Goztepe Tip Dergisi. 2009;24:129–33.
   Google Scholar
• Milo R, Miller A. Revised diagnostic criteria of multiple sclerosis. Autoimmun Rev. 2014;13:518–24.
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–52.
   PubMed Web of Science ®Google Scholar
• Yalachkov Y, Soydaş D, Bergmann J, et al. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis. Mult Scler Relat Disord. 2019;30:33–7.
   PubMed Web of Science ®Google Scholar
• Visser LA, Louapre C, Uyl-de Groot CA, et al. Health-related quality of life of multiple sclerosis patients: a European multi-country study. Arch Public Health. 2021;79(1):1–12.
   PubMed Web of Science ®Google Scholar
• Bolling J, Rusch CT, Kraus A, et al. (QOL19) The Mediterranean diet and fatigue, depression, and emotional well-being in multiple sclerosis: a study in patient-reported outcomes. Int J MS Care. 2020;22:68.
   Google Scholar
• Fitzgerald KC, Tyry T, Salter A, et al. Diet quality is associated with disability and symptom severity in multiple sclerosis. Neurology. 2018;90:14.
   PubMedGoogle Scholar
• Moravejolahkami AR, Paknahad Z, Chitsaz A. Association of dietary patterns with systemic inflammation, quality of life, disease severity, relapse rate, severity of fatigue and anthropometric measurements in MS patients. Nutr Neurosci. 2020;23:920–30.
   PubMed Web of Science ®Google Scholar
• Jelinek GA, Weiland TJ, Hadgkiss EJ, et al. The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Neurol Res. 2015;37:662–73.
   PubMed Web of Science ®Google Scholar
• Katz S. The role of diet in multiple sclerosis: mechanistic connections and current evidence. Curr Nutr Rep. 2018;7:150–60.
   PubMedGoogle Scholar
• Riccio P, Rossano R. Diet, gut microbiota, and vitamins D + A in multiple sclerosis. Neurotherapeutics. 2018;15:75–91.
   PubMed Web of Science ®Google Scholar
• Calder PC. n Ϫ 3 Polyunsaturated fatty acids, inflammation, and inflammatory. 2006;83.
   Google Scholar
• Farooqui AA, Horrocks LA, Farooqui T. Modulation of inflammation in brain: a matter of fat. J Neurochem. 2007;101:577–99.
   PubMed Web of Science ®Google Scholar
• Coe S, Tektonidis TG, Coverdale C, et al. A cross sectional assessment of nutrient intake and the association of the inflammatory properties of nutrients and foods with symptom severity, in a large cohort from the UK Multiple Sclerosis Registry. Nutr Res. 2020;85:31–39.
   PubMed Web of Science ®Google Scholar
• Riccio P. The molecular basis of nutritional intervention in multiple sclerosis: a narrative review. Complem Ther Med. 2011;19:228–37.
   PubMed Web of Science ®Google Scholar
• Bomprezzi R, Chen AP, Hemond CC. Cervical spondylosis is a risk factor for localized spinal cord lesions in multiple sclerosis. Clin Neurol Neurosurg. 2020;199:106311.
   PubMed Web of Science ®Google Scholar
• Manouchehrinia A, Westerlind H, Kingwell E, et al. Age related multiple sclerosis severity score: disability ranked by age. Mult Scler. 2017;23(14):1938–1946.
   PubMed Web of Science ®Google Scholar
• Jongen PJ. Health-related quality of life in patients with multiple sclerosis: impact of disease-modifying drugs. CNS Drugs. 2017;31(7):585–602.
   PubMed Web of Science ®Google Scholar
• Mokhber N, Azarpazhooh A, Orouji E, et al. Therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis. Psychiatry Clin Neurosci. 2015;69(10):649–657.
   PubMed Web of Science ®Google Scholar
• Torkildsen O, Myhr KM, Bø L. Disease-modifying treatments for multiple sclerosis – a review of approved medications. Eur J Neurol. 2016;23:18–27.
   PubMed Web of Science ®Google Scholar